Skip to search formSkip to main contentSkip to account menu

Cryptaz

Known as: Romark Brand 2 of Nitazoxanide 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

nitazoxanide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
FDA panel rejects drug for cryptosporidial diarrhea. Food and Drug Administration.
The approval of nitazoxanide (NTZ, Cryptaz) was rejected by the Food and Drug Administration (FDA) due to insufficient evidence… 
1998
1998
Diarrhea drug rejection raises a ruckus.
The Food and Drug Administration's (FDA) Advisory Committee has voted against approval of NTZ (Cryptaz) for treating… 
1998
1998
NTZ--still promising but Unimed walks.
The FDA Advisory Committee recommended that Unimed's NTZ (Cryptaz) not be approved until more data is presented. The PWA Health… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)